InnoPharmax, Inc. will attend BIO-Europe 2026, to be held from November 9 to November 11, 2026, at Koelnmesse in Cologne, Germany.

   BIO-Europe is a key international partnering event for the biotechnology and pharmaceutical industries, bringing together biotech companies, pharmaceutical companies, investors, licensing partners, and industry professionals from around the world. The event provides an important platform for discussions on licensing, co-development, strategic partnerships, clinical development, and business development opportunities.

   Through this event, InnoPharmax looks forward to reconnecting with long-term partners and engaging with potential collaborators to explore opportunities in international licensing, co-development, clinical development collaboration, and regional market expansion.

   During BIO-Europe 2026, InnoPharmax will introduce its development pipeline, finished products, the global Phase 3 clinical trial of GemOral®, and the potential application of its proprietary oral drug delivery platform, OralPAS®, in the co-development of candidate products.

   Industry partners and potential collaborators are welcome to connect with the InnoPharmax team to arrange meetings during BIO-Europe 2026 and explore future collaboration opportunities.

   LinkedIn：https://www.linkedin.com/feed/update/urn:li:activity:7511246925170434048